Abstract
This study was aimed at developing a nanoparticles system for curcumin, a widely used traditional Chinese medicine, but with the disadvantage of poor aqueous solubility. The objective was intended to improve in vitro release characteristics, enhance blood and gastrointestinal stability, increase bioavailability and pharmacological activities. Curcumin nanoparticles system (Cur-NS) was prepared by ionotropic gelation technique. Cur-NS was characterized by particle size, zeta potential, drug entrapment efficiency, drug loading, and physical stability, respectively. Cur-NS presented controlled release properties, and the release properties of Cur from NS were fit non-Fickian mechanism, controlled by the expected diffusional release and the erosion or solubilization from the crosslink layer of polymer carrier. In addition, the pharmacokinetic study in rats revealed a notable improved oral bioavailability of Cur, and the anti-tumor activity in vivo of Cur-NS on tumor growth was investigated. Cur-NS significantly inhibited tumor effect compared with non-vehicle group, thus making it a potential candidate for cancer therapy.
Similar content being viewed by others
References
Agarwal A, Lvov Y, Sawant R, Torchilin V (2008) Stable nanocolloids of poorly soluble drugs with high drug content prepared using the combination of sonication and layer-by-layer technology. J Control Release 128:255–260. doi:10.1016/j.jconrel.2008.03.017
Aggarwal BB, Sung B (2009) Pharmacological basis for the role of curcumin in chronic diseases: an ageold spice with modern targets. Trends Pharmacol Sci 30:85–94. doi:10.1016/j.tips.2008.11.002
Aggarwal BB, Yuan W, Li S, Gupta SC (2013) Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: identification of novel components of turmeric. Mol Nutr Food Res 57:1529–1542. doi:10.1002/mnfr.201200838
Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharmacol 4:807–818. doi:10.1021/mp700113r
Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB (2008) Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Lett 267:133–164. doi:10.1016/j.canlet.2008.03.025
Basnet P, Skalko-Basnet N (2011) Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 16:498–4567. doi:10.3390/molecules16064567
Bhavsar MD, Amiji MM (2007) Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS). J Control Release 119:339–348. doi:10.1016/j.jconrel.2007.03.00
Bhawana, Basniwal RK, Buttar HS, Jain VK, Jain N (2011) Curcumin nanoparticles: preparation, characterization and antimicrobial study. J Agric Food Chem 59:2056–2061. doi:10.1021/jf104402t
Bonderer LJ, Studart AR, Gauckler LJ (2008) Bioinspired design and assembly of platelet reinforced polymer films. Science 319:1069–1073. doi:10.1126/science.1148726
Hatcher H, Planalp R, Cho J, Torti FM, Torti SV (2008) Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 65:1631–1652. doi:10.1007/s00018-008-7452-4
Khalil SK, El-Feky GS, El-Banna ST, Khalil WA (2012) Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery. Carbohydr Polym 90:1244–1253. doi:10.1016/j.carbpol.2012.06.056
Kumar A, Ahuja A, Ali J, Baboota S, Baboota S (2010) Conundrum and therapeutic potential of curcumin in drug delivery. Crit Rev Ther Drug Carrier Syst 27:279–312. doi:10.1615/CritRevTherDrugCarrierSyst.v27.i4.10
Pari L, Tewas D, Eckel J (2008) Role of curcumin in health and disease. Arch Physiol Biochem 114:127–149. doi:10.1080/13813450802033958
Sharma RA, Steward WP, Gescher AJ (2007) Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol 595:453–470. doi:10.1007/978-0-387-46401-5_20
Shehzad A, Wahid F, Lee YS (2010) Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim) 343:489–499. doi:10.1002/ardp.200900319
Sun W, Zou W, Huang G, Li A, Zhang N (2008) Pharmacokinetics and targeting property of TFu-loaded liposomes with different sizes after intravenous and oral administration. J Drug Target 16:357–365. doi:10.1080/10611860801927598
Sun W, Zhang N, Li X (2012) Release mechanism studies on TFu nanoparticles-in-microparticles system. Colloids Surf B Biointerfaces 95:115–120. doi:10.1016/j.colsurfb.2012.02.019
Wilken R, Veena MS, Wang MB, Srivatsan ES (2011) Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 10:10–12. doi:10.1186/1476-4598-10-12
Yadav SK, Sah AK, Jha RK, Sah P, Shah DK (2013) Turmeric (curcumin) remedies gastroprotective action. Pharmacogn Rev 7:42–46. doi:10.4103/0973-7847.112843
Yang KY, Lin LC, Tseng TY, Wang SC, Tsai TH (2007) Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC–MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 853:183–189. doi:10.1016/j.jchromb.2007.03.010
Zhang H, Zhang L, Yuan P, Wang C (2011) Preparation and in vitro release characteristics of curcumin in nanosuspensions. Zhongguo Zhong Yao Za Zhi 36:132–135. doi:10.4268/cjcmm20110209
Acknowledgments
This research was supported in part by grants from the Administration of Traditional Chinese Medicine of Heilongjiang Program (Grant No. ZHY12-Z194), the Natural Science Youth Foundation (Grant No. Sq2012-47), the Heilongjiang education department natural science research (Grant No. 12531667), and financed by the National Undergraduate Training Programs for Innovation and Entrepreneurship (201310222046), and Natural Science Foundation of Heilongjiang Province (Grant No. D201158).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sun, W., Zou, Y., Guo, Y. et al. Construction and characterization of curcumin nanoparticles system. J Nanopart Res 16, 2317 (2014). https://doi.org/10.1007/s11051-014-2317-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-014-2317-2